
Parul University
Vadodara, Gujarat
- Avg package
- ₹7 LPA
Explore top pharmacy colleges in India. Compare their courses, fees, placements and admission requirements, and find the programme that fits your goals.
Pharmacy is the science of medicines, how they are discovered, formulated, manufactured, quality-tested, regulated, dispensed and monitored once patients start taking them. In India, pharmacy education runs as a well-defined ladder: the two-year Diploma in Pharmacy (D.Pharm) for entry into dispensing practice, the four-year Bachelor of Pharmacy (B.Pharm) as the standard industry and higher-study gateway, the two-year Master of Pharmacy (M.Pharm) with focused specializations such as pharmaceutics, pharmacology and regulatory affairs, the six-year clinically oriented Doctor of Pharmacy (Pharm.D), and doctoral (PhD) research. A distinctive feature of the profession is that it is legally gated: to practise as a pharmacist, that is, to dispense medicines in a community or hospital pharmacy, a candidate must hold a PCI-approved qualification and be registered with a State Pharmacy Council under the Pharmacy Act, 1948.
The Pharmacy Council of India (PCI) is the statutory regulator of the profession. Constituted on 4 March 1948 under the Pharmacy Act, 1948 and functioning under the Ministry of Health and Family Welfare, the PCI prescribes the minimum standard of education required to qualify as a pharmacist, frames course regulations (Education Regulations 2020 for D.Pharm, the B.Pharm and M.Pharm Course Regulations 2014, the Pharm.D Regulations 2008), approves institutions under Section 12 of the Act, and maintains the Central Register of Pharmacists. Registration itself happens at the state level under Section 33. The PCI has also notified an exit examination for diploma holders, the Diploma in Pharmacy Exit Examination (DPEE), under the DPEE Regulations 2022, conducted through the National Board of Examinations in Medical Sciences (NBEMS), as a competency check before D.Pharm graduates are registered; its rollout has seen phased implementation and periodic relaxations, so candidates should track current PCI notifications.
The industry that absorbs most pharmacy graduates is one of India's genuine global success stories. Often called the "pharmacy of the world", the Indian pharmaceutical industry is the third largest in the world by volume and roughly the thirteenth largest by value, valued at about US$50 billion in FY 2023-24. India supplies around one-fifth of global generic medicine demand, including nearly half of all generic prescriptions by volume in the United States, and accounts for over 60% of the world's vaccine production, anchored by the Serum Institute of India, the world's largest vaccine maker. Indian pharmaceutical exports crossed US$25 billion in FY 2022-23 and reach more than 200 countries, with about 70% going to highly regulated markets such as North America and Europe. Companies like Sun Pharma, Cipla, Dr. Reddy's Laboratories, Lupin, Zydus and Aurobindo, together with a deep contract research and manufacturing (CRAMS/CDMO) ecosystem, generate steady demand for production, quality, regulatory and research talent.
Admissions work differently at each rung. D.Pharm and B.Pharm seats are filled largely through state-level common entrance tests, the MHT CET pharmacy group in Maharashtra, WBJEE in West Bengal, KCET, AP/TS EAPCET, KEAM and similar exams elsewhere, or through 10+2 merit where no CET applies; both mathematics and biology students are eligible, since 10+2 with Physics and Chemistry plus either Biology or Mathematics satisfies PCI norms. At the postgraduate level the Graduate Pharmacy Aptitude Test (GPAT), begun in 2010 under AICTE, run by the NTA from 2019 to 2023, and conducted since 2024 by the PCI through NBEMS, is the principal national gateway to M.Pharm seats and carries a monthly scholarship of ₹12,400 for qualified candidates in approved institutions. The seven National Institutes of Pharmaceutical Education and Research (NIPERs), Institutes of National Importance under the Department of Pharmaceuticals, admit to their master's and PhD programmes through the separate NIPER Joint Entrance Examination, for which a valid GPAT/GATE/NET score is a prerequisite.
Career outcomes span a wider spectrum than the stereotypical medical store. Graduates enter pharmaceutical production, quality assurance and quality control, regulatory affairs, clinical research, pharmacovigilance, medical writing, formulation and discovery R&D, sales and marketing, hospital and community practice, government roles such as drug inspector, and academia. The rise of clinical pharmacy: Pharm.D graduates now anchor hospital Drug Information Centres and a formal clinical pharmacist cadre, and the rapid growth of India's pharmacovigilance and regulatory outsourcing industry keep expanding the non-manufacturing side of the profession. Entry salaries are modest (roughly ₹2 to 4 LPA in retail and production roles) but climb meaningfully with specialization, with regulatory affairs, R&D and clinical research professionals commonly reaching ₹8 to 15 LPA at mid-career; all figures on this page are indicative annual ranges, not guarantees.
Diploma · 2 years
Pass in 10+2 (science stream) with Physics, Chemistry and either Biology or Mathematics, from a PCI-approved institution's admission norms; minimum age norms per state rules
Duration: 2 years, plus 500 hours of practical training and (as notified) the Diploma in Pharmacy Exit Examination before registration
Undergraduate · 4 years
10+2 with Physics, Chemistry and either Biology or Mathematics (both PCB and PCM students are eligible); lateral entry to 2nd year for D.Pharm holders from PCI-approved institutions
Duration: 4 years (8 semesters); D.Pharm holders may join the 2nd year via lateral entry
Undergraduate · 2 academic years
D.Pharm from a PCI-approved institution (Section 12, Pharmacy Act 1948) + current registration as a pharmacist + minimum 4 years of pharmacy practice experience in a community or hospital pharmacy, evidenced by drug-licence endorsement or an employer certificate
Duration: 2 academic years (each of not less than 180 working days)
Direct admission at PCI-approved institutions offering the course, against documentary proof of registration and practice experience; seats are limited and the course is offered by relatively few institutions
Postgraduate · 2 years
B.Pharm from a PCI-approved institution, typically with at least 55% marks (relaxations for reserved categories); most reputed institutions require a valid GPAT score
Duration: 2 years (4 semesters), including a research dissertation in the second year
Doctoral · 6 years
10+2 with Physics, Chemistry and Biology or Mathematics, or a D.Pharm, for the 6-year programme; B.Pharm graduates for the 3-year Post Baccalaureate track; offered only at PCI-approved Pharm.D institutions attached to teaching hospitals
Duration: 6 years (5 years of study + 1 year internship/residency); Pharm.D (Post Baccalaureate) after B.Pharm: 3 years (2 years study + 1 year internship)
Doctoral · 3 to 6 years
M.Pharm / MS (Pharm) / M.Tech (Pharm) or Pharm.D (direct PhD registration permitted since 2012) in a relevant discipline, usually with 55 to 60% marks; fellowships generally require GPAT, GATE, CSIR-UGC NET or equivalent national qualifications
Duration: Typically 3 to 6 years after a master's degree (full-time); part-time options exist for working professionals
The D.Pharm is the shortest route into the pharmacy profession and remains the workhorse qualification behind India's vast network of retail medical stores and hospital dispensaries. Governed by the PCI's Education Regulations 2020 (ER-2020), the course runs two academic years and covers the essentials of pharmaceutics, pharmaceutical chemistry, pharmacology, pharmacognosy, hospital and community pharmacy, biochemistry and pharmacy law. ER-2020 modernized a decades-old syllabus, strengthening the practice orientation of the diploma and making 500 hours of supervised practical training, split across a hospital pharmacy and a community pharmacy and documented in a preceptor-signed logbook, a compulsory component.
The B.Pharm is the standard professional degree of Indian pharmacy and the qualification most pharmaceutical employers treat as the baseline. Regulated by the PCI's B.Pharm Course Regulations, 2014 under a semester-wise choice-based credit system, the four-year programme builds a complete map of the medicine lifecycle: dosage-form science (pharmaceutics), drug molecules and their synthesis (pharmaceutical/medicinal chemistry), how drugs act on the body (pharmacology), natural-product drugs (pharmacognosy), analysis and quality assurance, microbiology and biotechnology, pharmacy law, and industrial pharmacy including regulatory science. The regulations mandate at least 150 hours of practical training after the lower years, undertaken either in hospital/community practice or in pharmaceutical and allied industries, and D.Pharm holders enter directly into the second year with 52 credits transferred plus remedial modules in communication skills and computer applications.
B.Pharm (Practice) is a special-purpose bachelor's degree the PCI created through the Bachelor of Pharmacy (Practice) Regulations, 2014, to give India's large workforce of practising diploma pharmacists a route to a degree qualification without abandoning their practice orientation. Unlike lateral-entry B.Pharm, which drops a D.Pharm holder into the conventional industry-focused degree: B.Pharm (Practice) is designed around the realities of community and hospital pharmacy: its two-year curriculum emphasises pharmacotherapeutics, patient counselling, drug information, hospital pharmacy management, community pharmacy services and pharmacoepidemiology rather than manufacturing science.
The M.Pharm converts a generalist pharmacy graduate into a specialist, and specialization choice is the single most career-defining decision of the degree. Under the PCI's M.Pharm Course Regulations, 2014, recognized specializations include Pharmaceutics, Industrial Pharmacy, Pharmaceutical Technology, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Quality Assurance, Regulatory Affairs, Pharmaceutical Biotechnology, Pharmacy Practice, Pharmacology, Pharmacognosy, and Phytopharmacy & Phytomedicine. Broadly, pharmaceutics and industrial pharmacy feed formulation development (F&D) and production leadership; pharmaceutical chemistry and analysis feed synthesis and analytical R&D; pharmacology feeds preclinical research, medical affairs and pharmacovigilance; quality assurance and regulatory affairs feed the compliance functions that India's export-heavy industry depends on; pharmacognosy connects to the phytopharmaceutical and nutraceutical sector.
The Pharm.D is India's clinical pharmacy doctorate, introduced in 2008 by the Government of India and the PCI (Pharm.D Regulations, 2008) to build a workforce of patient-facing medicines experts on the American model. The six-year programme front-loads biomedical and pharmaceutical sciences, then pivots decisively to the bedside: pharmacotherapeutics, clinical pharmacokinetics and therapeutic drug monitoring, hospital and clinical pharmacy, clinical research and pharmacoepidemiology, with hospital postings woven through the fourth and fifth years and a full sixth year of internship/residency in a teaching hospital, rotating through medicine, surgery and specialty wards. A three-year Post Baccalaureate variant (two years of study plus the internship year) lets B.Pharm graduates convert to the clinical track.
A PhD in pharmaceutical sciences is the research apex of the stream, and in India it is increasingly an industry-relevant degree rather than a purely academic one. Doctoral work spans novel drug delivery systems and nanomedicine, medicinal chemistry and computer-aided drug design, pharmacology and toxicology, pharmaceutical analysis, biotechnology and biologics, natural-product chemistry, and pharmacy practice research. The strongest ecosystems are at the seven NIPERs (Institutes of National Importance under the Department of Pharmaceuticals, admitting through NIPER JEE), ICT Mumbai, BITS Pilani, Jamia Hamdard, Panjab University, and CSIR laboratories such as CDRI Lucknow and IICT Hyderabad, alongside doctoral programmes embedded in company R&D collaborations.

Vadodara, Gujarat

Coimbatore, Tamil Nadu

Jamshedpur, Jharkhand

Kolkata, West Bengal

Surat, Gujarat

Pilani, Rajasthan

Jaipur, Rajasthan

Ahmedabad, Gujarat

Jalandhar, Punjab
Salary figures are indicative ranges and vary by college, location, and experience.
Pharmacy programmes prepare students for a range of professional and higher-study pathways. Browse the colleges below to understand the courses on offer, the degrees awarded and the institutes best suited to your interests.
Starting salaries vary by course, college and role. Explore individual colleges and courses for placement details where available.
Entrance exams, counselling rules and eligibility can change each academic year. Always verify the current admission brochure of the university. State counselling authority, and relevant council.
Chemistry, biology, formulation, lab work, quality control, regulatory documentation, patient counselling, drug safety, manufacturing processes, accuracy, ethics.
Good for students interested in medicines, chemistry, healthcare products, pharmaceutical industry, lab work, and healthcare business.
Choose by destination, not by degree length. B.Pharm (4 years) is the industry degree: it leads to production, quality, regulatory, R&D and sales roles, to GPAT/M.Pharm, and it costs two years less. Pharm.D (6 years, including a one-year hospital internship) is the clinical degree: it trains you to work with patients and prescriptions inside hospitals, anchors the clinical-pharmacist cadre and Drug Information Centres, permits the 'Dr.' prefix, and allows direct PhD registration. If you want laboratories, factories or corporate roles, take B.Pharm; if you want bedside pharmacy practice or Gulf-country clinical roles, Pharm.D fits better. B.Pharm graduates who later discover a clinical calling can still switch via the 3-year Pharm.D (Post Baccalaureate).
Four concrete ones. First, admission: GPAT rank is the primary currency for M.Pharm seats at approved institutions, including centralized state counselling. Second, money: GPAT-qualified students admitted to AICTE/PCI-approved PG programmes receive a ₹12,400 monthly scholarship for the full two years, over ₹2.9 lakh in total, which offsets most fees at many colleges. Third, eligibility: a valid GPAT (or GATE/NET) score is a precondition to even apply for NIPER JEE, and BITS Pilani fills up to half its M.Pharm seats directly on GPAT merit. Fourth, signalling: several PSU and research recruiters treat a good GPAT score as a screening credential. Scores stay valid for three years.
Registration is mandatory only for practising as a pharmacist, dispensing medicines in a community or hospital pharmacy, or being the qualified person on a retail/wholesale drug licence. It is done with a State Pharmacy Council under Section 33 of the Pharmacy Act, 1948, on the strength of a PCI-approved qualification (D.Pharm, B.Pharm or Pharm.D). Industry roles, production, QA/QC, regulatory affairs, clinical research, pharmacovigilance, sales, do not legally require registration, though many professionals maintain it as a credential. Note the newer wrinkle for diploma holders: the PCI has notified the Diploma in Pharmacy Exit Examination (DPEE) as a pre-registration requirement for fresh D.Pharm graduates, with phased implementation, check current PCI notifications for your batch.
Either works. PCI norms for D.Pharm, B.Pharm and Pharm.D require 10+2 with Physics and Chemistry plus either Biology or Mathematics, and state CETs accommodate both: MHT CET lets pharmacy aspirants appear through the PCB group, the PCM group, or both (appearing in both maximizes counselling options), while WBJEE's pharmacy rank needs only the Physics-Chemistry paper. Inside the course, PCM students catch up on biology through anatomy-physiology and microbiology modules, while PCB students handle the modest mathematics (pharmacokinetics calculations) comfortably. Neither background is a real disadvantage.
They are almost different professions sharing a degree. Practice (community/hospital pharmacy) offers licence-protected work, local independence and, if you own the store, business income that can substantially beat salaried pay, but salaried dispensing roles themselves start low (₹2 to 4 LPA) and grow slowly. Industry offers structured careers with faster salary growth: a QA or regulatory professional can move from ₹3 to 4 LPA at entry to ₹10 to 15+ LPA in a decade, with global mobility, but demands relocation to manufacturing/R&D hubs and offers no ownership. A common hybrid: gain industry experience first, then return to entrepreneurship (pharmacy chains, distribution, small-scale manufacturing) with capital and compliance knowledge.
The seven National Institutes of Pharmaceutical Education and Research (Mohali, Ahmedabad, Guwahati, Hajipur, Hyderabad, Kolkata, Raebareli) are Institutes of National Importance under the Department of Pharmaceuticals, pharmacy's closest equivalent to the IITs. They offer MS (Pharm), M.Tech (Pharm), MBA (Pharm) and PhD programmes with strong faculty, instrumentation and industry linkage, and their graduates dominate R&D hiring and foreign PhD admissions. Entry is via NIPER JEE, a 200-question, 2-hour CBT, but only candidates who already hold a valid GPAT/GATE/NET score and 60% in B.Pharm may apply, which is why serious aspirants treat GPAT and NIPER JEE as one combined campaign.
Pharm.D holders may use the 'Dr.' prefix, the PCI has clarified the degree is a postgraduate-level Doctor of Pharmacy qualification, but it does not make them physicians. Pharm.D is approved by the PCI, not the National Medical Commission; graduates cannot diagnose independently or prescribe medicines as doctors of medicine do. Their legally recognized turf is medicines expertise: clinical pharmacy services, therapy review, drug information (hospitals' Drug Information Centres are mandated to be headed by Pharm.D graduates), pharmacovigilance and clinical research. Choosing Pharm.D expecting physician-equivalent authority or pay is the most common mis-sold expectation in this stream, evaluate it as a clinical pharmacy specialization, not an MBBS alternative.
There is no universal best, but the demand map is fairly stable. Pharmaceutics/Industrial Pharmacy has the broadest industry absorption (formulation development is every generic company's core function). Pharmaceutical Quality Assurance and Regulatory Affairs ride India's export compliance needs and offer strong mid-career pay. Pharmacology feeds pharmacovigilance, preclinical research and medical affairs, big office-based job pools. Pharmaceutical Analysis fits analytical R&D and QC method development. Pharmacy Practice mainly leads to clinical and academic roles. Pharmacognosy is narrower but aligned with the growing phytopharmaceutical/nutraceutical space. Pick the intersection of your interest and the function you actually want to work in; the college's placement record in that specific specialization matters more than the label.
Yes, the majority of B.Pharm graduates start work directly. Entry roles include production and QC/QA officer, regulatory affairs trainee, pharmacovigilance associate, clinical research coordinator, medical representative and hospital pharmacist, typically at ₹2.5 to 4.5 LPA. Government routes (drug inspector, government analyst, railway/ESIC/military pharmacist posts) recruit pharmacy graduates through competitive exams with pay-commission salaries. That said, a master's accelerates technical tracks: R&D and senior regulatory/QA roles list M.Pharm as standard, and teaching requires it. A pragmatic pattern is to work 1 to 2 years, identify the function you enjoy, then do a targeted M.Pharm, MBA (for sales/marketing/management) or certifications (regulatory affairs, clinical data management) accordingly.
The Diploma in Pharmacy Exit Examination, notified under the PCI's DPEE Regulations 2022 and conducted through NBEMS, is a competency test that fresh D.Pharm graduates must pass before a State Pharmacy Council registers them as pharmacists. It is a multi-paper MCQ examination covering pharmaceutics, pharmacology and pharmacy practice, with passing required in each paper. Implementation has been phased, the PCI has issued temporary relaxations allowing certain batches to register while the examination system stabilizes, so the operative requirement depends on your completion year and the latest PCI circular. Anyone planning a dispensing career on a D.Pharm should budget for the exam and follow pci.gov.in and natboard.edu.in notifications rather than assume exemption.
Structurally large and export-anchored. India's pharma industry, about US$50 billion in FY 2023-24 and projected to keep growing, is the world's third largest by volume, supplies roughly a fifth of global generic demand (including nearly half of US generic prescriptions by volume), produces over 60% of the world's vaccines, and exports to 200+ countries. That translates into sustained hiring across manufacturing hubs, QA/QC, regulatory affairs for filings in the US/EU, and a giant services layer (CROs, pharmacovigilance, medical writing) that global companies have offshored to India. The caveat: supply of graduates is also large, so entry-level pay is competitive; differentiation comes from specialization, English communication and regulatory-market exposure.
Treat all figures as indicative annual ranges. Fresh D.Pharm: ₹2 to 3.5 LPA in retail/hospital dispensing. Fresh B.Pharm: ₹2.5 to 4.5 LPA in production, QC or PV; medical reps similar plus incentives. Fresh M.Pharm/NIPER MS: ₹4 to 8 LPA in F&D, regulatory, QA or research, with top campuses higher. Pharm.D: ₹3.5 to 6 LPA in hospitals, ₹4 to 9 LPA in PV/medical writing. PhD: ₹8 to 15 LPA entering industry R&D. Mid-career (8 to 12 years), regulatory affairs, QA and R&D leads commonly earn ₹10 to 20 LPA, and heads of function more. Practice incomes hinge on pharmacy ownership and location. Salaries vary widely by city, company tier and specialization, verify current figures during placement research.
Compare pharmacy colleges across India (fees, placements, accreditation and courses) and shortlist the right fit for you.